| |
| |
|
| Insider
Information: |
Vasista Vittal |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
246,534 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,806,485 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
246,534 |
|
|
| Total
Value |
$3,806,485 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regenxbio Inc. |
RGNX |
|
2024-03-19 |
246,534 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2024-03-19 |
4 |
OE |
$3.76 |
$75,354 |
D/D |
20,041 |
246,534 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,026 |
226,493 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
D |
$17.95 |
$81,385 |
D/D |
(4,534) |
210,467 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2023-05-31 |
4 |
OE |
$0.85 |
$29,750 |
D/D |
35,000 |
215,001 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
46,174 |
180,001 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$22.68 |
$30,232 |
D/D |
(1,333) |
133,827 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-08-30 |
4 |
AS |
$30.24 |
$72,573 |
D/D |
(2,400) |
135,160 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
AS |
$35.19 |
$608,035 |
D/D |
(17,280) |
137,560 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-08-04 |
4 |
AS |
$35.00 |
$14,000 |
D/D |
(400) |
154,840 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-08-01 |
4 |
AS |
$31.26 |
$75,012 |
D/D |
(2,400) |
155,240 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-07-14 |
4 |
AS |
$30.00 |
$14,040 |
D/D |
(468) |
157,640 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-07-13 |
4 |
AS |
$30.01 |
$129,988 |
D/D |
(4,332) |
158,108 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-01-20 |
4 |
OE |
$0.85 |
$25,415 |
D/D |
29,900 |
162,440 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,900 |
132,540 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-07-27 |
4 |
OE |
$0.85 |
$8,500 |
D/D |
10,000 |
123,640 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-15 |
4 |
AS |
$50.04 |
$12,610 |
D/D |
(252) |
113,640 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-14 |
4 |
AS |
$50.03 |
$554,983 |
D/D |
(11,093) |
113,892 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-12 |
4 |
AS |
$50.01 |
$210,042 |
D/D |
(4,200) |
124,985 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-08 |
4 |
AS |
$46.45 |
$246,715 |
D/D |
(5,241) |
129,185 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-07 |
4 |
AS |
$50.00 |
$549,900 |
D/D |
(10,998) |
134,426 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,400 |
145,424 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2020-12-24 |
4 |
AS |
$50.00 |
$168,800 |
D/D |
(3,376) |
133,024 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2020-12-23 |
4 |
AS |
$50.01 |
$1,056,411 |
D/D |
(21,124) |
136,400 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2020-12-11 |
4 |
AS |
$40.17 |
$599,176 |
D/D |
(14,916) |
157,524 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Financial Officer |
• – – |
2020-12-10 |
4 |
AS |
$40.06 |
$904,715 |
D/D |
(22,584) |
172,440 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
